DEALING WITH QUALITY OF LIFE MISSING DATA IN A SINGLE ARM STUDY. COMPARISON OF MULTIPLE IMPUTATION METHODS
Author(s)
Anke van Engen, MSc, Director Operations Europe1, Aude Arnault, MSc, Jr Consultant Outcomes Research2, Cristina Ivanescu, PhD, Sr Consultant Outcomes Research1, Pascale Peeters, Dr, Associate Director21Quintiles Consulting, Hoofddorp, Netherlands; 2 Quintiles Consulting, Levallois-Perret, France
OBJECTIVES: Assessment of Quality of Life (QoL), a Patient Reported Outcome (PRO), has gained acceptance as a study endpoint. An open-label, multicenter phase II, single arm oncology study was conducted with a QoL endpoint aiming to assess change of scores from baseline to 12-week or End of Study (whichever occurred first). This required the availability of the baseline and at least one post-baseline assessment. Unfortunately, missing data affects the validity of QoL assessment. A set of different techniques to deal with missing data was compared.METHODS: The analysis addressed the global health status scale (QL range [1;100]) of QLQ-C30, the EQ-5D utility index (Utility range [0;1]) and Visual Analysis Scale (VAS range [0;100]). Five multiple imputation (MI) techniques were carried out with two softwares (SAS, IVEware) and compared with Rubin’s efficiency: Monte-Carlo Markov Chain (MCMC), Expectation-Maximization (EM), Regression (REG), Propensity score (PROP) and Sequential regression (SEQ), using 5 simulations per technique. RESULTS: Changes significance varied depending on the imputation technique. At baseline, mean scores were: QL 0.73, EQ-5D index 63.4, and VAS 68. For QL score, the change estimations were (mean [95%CI]): -1.699 [-3.322;-0.076] (MCMC), -1.558 [-3.132;0.015] (EM), -1.795 [-3.449;-0.141] (REG), -1.197 [-3.067,0.673] (PROP), -0.895 [-5.622;3.832] (SEQ). For EQ-5D index, estimations were: -0.020 [-0.042;0.003] (MCMC), -0.018 [-0.043;0.007] (EM), -0.018 [-0.034;-0.002] (REG), -0.015 [-0.045;0.014] (PROP), -0.010 [-0.049;0.030] (SEQ). VAS changes varied from 0.019 (SEQ) to 0.791 (PROP), no change estimation was significant. Rubin’s efficiency was comprised between 88.32% and 94.43% depending on score and technique.CONCLUSIONS: Results have to be carefully interpreted since they vary according to the MI method. SEQ is the only method not assuming a normal distribution of the data and consequently displays large confidence intervals. Nevertheless, multiple imputation is told to be robust to normality. A sensitivity analysis is advised in order to compare the different results.
Conference/Value in Health Info
2008-11, ISPOR Europe 2008, Athens, Greece
Value in Health, Vol. 11, No. 6 (November 2008)
Code
PCN109
Topic
Methodological & Statistical Research
Topic Subcategory
PRO & Related Methods
Disease
Oncology